NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|568953947|ref|XP_006509110|]
View 

indoleamine 2,3-dioxygenase 2 isoform X2 [Mus musculus]

Protein Classification

indoleamine 2,3-dioxygenase( domain architecture ID 10472220)

indoleamine 2,3-dioxygenase (IDO) catalyzes the first step in tryptophan catabolism in order to supply de novo nicotinamide adenine dinucleotide (NAD(+)) via the kynurenine pathway

CATH:  1.20.58.480
EC:  1.13.11.52
Gene Ontology:  GO:0020037|GO:0046872|GO:0033754
SCOP:  4001604

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
IDO pfam01231
Indoleamine 2,3-dioxygenase;
1-334 3.19e-163

Indoleamine 2,3-dioxygenase;


:

Pssm-ID: 460123  Cd Length: 406  Bit Score: 461.62  E-value: 3.19e-163
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947    1 MPLLDCRFLKSYREQRLAHMALAAITMGFVWQEGEgQPQKVLPRSLAIPFVEVSRNLGLPPILVHSDLVLTNWTKRN-PE 79
Cdd:pfam01231  53 LPVLSTDQLESELELRRAHLVLAFLTHAYVWGEGD-KPSEVLPPSIAVPLLEVSEHLGLPPVLTYADLVLWNWKPIDgPE 131
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947   80 GPLEISNLETIISFPGGESLRGFILVTVLVEKAAVPGLKALVQGMEAIRQHSQDTLLEALQQLRLSIQDITRALAQMHDY 159
Cdd:pfam01231 132 DPMDLDNLRILNTFTGTEDESWFYLVSVAIEARGAPALPLMLQAIDAARDGDAARVTSALQSLAEVIDELGLLLMRMYEH 211
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947  160 VDPDIFYSVIRIFLSGWKDNPA--MPVGLVYEGVATEPLKYSGGSAAQSSVLHAFDEFLGIEHC-------KESVGFLHR 230
Cdd:pfam01231 212 CDPHVFYHRIRPFLAGSKNMADagLPNGVIYEGVEGEPRQYSGGSAAQSSLIQFFDIFLGVEHSptspspkSSSASFLQR 291
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947  231 MRDYMPPSHKAFLEDLHVAPSLRDYILASGPGDCLM-AYNQCVEALGELRSYHINVVARYIISAATRARSRGLTNPS--- 306
Cdd:pfam01231 292 MRDYMPGPHRRFLEHLESVPSIREFVLSCGDLKSLReAYNACVAALKRFRDKHIQIVTRYIIIPARRAPPKQSSDLEtst 371
                         330       340       350
                  ....*....|....*....|....*....|....*
gi 568953947  307 -------PHALEDRGTGGTAMLSFLKSVREKTMEA 334
Cdd:pfam01231 372 rapaaaePSEKELKGTGGTDLIPFLKQVRDETGEA 406
 
Name Accession Description Interval E-value
IDO pfam01231
Indoleamine 2,3-dioxygenase;
1-334 3.19e-163

Indoleamine 2,3-dioxygenase;


Pssm-ID: 460123  Cd Length: 406  Bit Score: 461.62  E-value: 3.19e-163
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947    1 MPLLDCRFLKSYREQRLAHMALAAITMGFVWQEGEgQPQKVLPRSLAIPFVEVSRNLGLPPILVHSDLVLTNWTKRN-PE 79
Cdd:pfam01231  53 LPVLSTDQLESELELRRAHLVLAFLTHAYVWGEGD-KPSEVLPPSIAVPLLEVSEHLGLPPVLTYADLVLWNWKPIDgPE 131
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947   80 GPLEISNLETIISFPGGESLRGFILVTVLVEKAAVPGLKALVQGMEAIRQHSQDTLLEALQQLRLSIQDITRALAQMHDY 159
Cdd:pfam01231 132 DPMDLDNLRILNTFTGTEDESWFYLVSVAIEARGAPALPLMLQAIDAARDGDAARVTSALQSLAEVIDELGLLLMRMYEH 211
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947  160 VDPDIFYSVIRIFLSGWKDNPA--MPVGLVYEGVATEPLKYSGGSAAQSSVLHAFDEFLGIEHC-------KESVGFLHR 230
Cdd:pfam01231 212 CDPHVFYHRIRPFLAGSKNMADagLPNGVIYEGVEGEPRQYSGGSAAQSSLIQFFDIFLGVEHSptspspkSSSASFLQR 291
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947  231 MRDYMPPSHKAFLEDLHVAPSLRDYILASGPGDCLM-AYNQCVEALGELRSYHINVVARYIISAATRARSRGLTNPS--- 306
Cdd:pfam01231 292 MRDYMPGPHRRFLEHLESVPSIREFVLSCGDLKSLReAYNACVAALKRFRDKHIQIVTRYIIIPARRAPPKQSSDLEtst 371
                         330       340       350
                  ....*....|....*....|....*....|....*
gi 568953947  307 -------PHALEDRGTGGTAMLSFLKSVREKTMEA 334
Cdd:pfam01231 372 rapaaaePSEKELKGTGGTDLIPFLKQVRDETGEA 406
 
Name Accession Description Interval E-value
IDO pfam01231
Indoleamine 2,3-dioxygenase;
1-334 3.19e-163

Indoleamine 2,3-dioxygenase;


Pssm-ID: 460123  Cd Length: 406  Bit Score: 461.62  E-value: 3.19e-163
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947    1 MPLLDCRFLKSYREQRLAHMALAAITMGFVWQEGEgQPQKVLPRSLAIPFVEVSRNLGLPPILVHSDLVLTNWTKRN-PE 79
Cdd:pfam01231  53 LPVLSTDQLESELELRRAHLVLAFLTHAYVWGEGD-KPSEVLPPSIAVPLLEVSEHLGLPPVLTYADLVLWNWKPIDgPE 131
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947   80 GPLEISNLETIISFPGGESLRGFILVTVLVEKAAVPGLKALVQGMEAIRQHSQDTLLEALQQLRLSIQDITRALAQMHDY 159
Cdd:pfam01231 132 DPMDLDNLRILNTFTGTEDESWFYLVSVAIEARGAPALPLMLQAIDAARDGDAARVTSALQSLAEVIDELGLLLMRMYEH 211
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947  160 VDPDIFYSVIRIFLSGWKDNPA--MPVGLVYEGVATEPLKYSGGSAAQSSVLHAFDEFLGIEHC-------KESVGFLHR 230
Cdd:pfam01231 212 CDPHVFYHRIRPFLAGSKNMADagLPNGVIYEGVEGEPRQYSGGSAAQSSLIQFFDIFLGVEHSptspspkSSSASFLQR 291
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 568953947  231 MRDYMPPSHKAFLEDLHVAPSLRDYILASGPGDCLM-AYNQCVEALGELRSYHINVVARYIISAATRARSRGLTNPS--- 306
Cdd:pfam01231 292 MRDYMPGPHRRFLEHLESVPSIREFVLSCGDLKSLReAYNACVAALKRFRDKHIQIVTRYIIIPARRAPPKQSSDLEtst 371
                         330       340       350
                  ....*....|....*....|....*....|....*
gi 568953947  307 -------PHALEDRGTGGTAMLSFLKSVREKTMEA 334
Cdd:pfam01231 372 rapaaaePSEKELKGTGGTDLIPFLKQVRDETGEA 406
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH